-
Sector Analysis
NewPetrochemicals Capacity and Capital Expenditure Outlook by Region, Countries, Companies, Commodity, Projects and Forecast to 2030
Petrochemicals Capacity & Capital Expenditure (Capex) Overview The petrochemicals capacity was 2600.06 million tonnes per annum (mtpa) in 2023. Asia, the Middle East, and the Former Soviet Union are the top regions contributing to capacity additions in the upcoming years. In the Middle East, most capacity additions are in Iran while in FSU, the majority of capacity additions are in Russia. Petrochemicals Capacity and Capex Outlook, 2023-2030 (mtpa) Buy the Full Report for More Insights on Petrochemicals Capacity and Capex...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IVS-1001 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IVS-1001 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IVS-1001 in Non-Small Cell Lung Cancer Drug Details: UCPVax...
-
Product Insights
Hip Reconstruction – United Orthopedic Corp – UCP
GlobalData, the industry analysis specialist, has released its latest report: Hip Reconstruction - United Orthopedic Corp - UCP. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted by the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – IVS-1001
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry IVS-1001 Drug Details UCPVax is under development for the treatment of metastatic squamous cell...
-
Product Insights
Parasitology and Mycology Rapid Tests and POC – Medical Devices Pipeline Assessment, 2020
Parasitology & Mycology Rapid Tests & POC comprises of rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for the detection of pathogenic protozoans and fungi. GlobalData's Medical Devices sector report, “Parasitology & Mycology Rapid Tests & POC-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Parasitology & Mycology Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in...